A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

NCT04784533 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

317

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: CTP-543
DRUG: Placebo

Sponsor

Concert Pharmaceuticals